• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Nova Biomedical

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
  Class 2 Device Recall Nova Biomedical see related information
Date Initiated by Firm March 30, 2004
Date Posted July 20, 2004
Recall Status1 Terminated 3 on June 17, 2004
Recall Number Z-0828-04
Recall Event ID 28725
Product Classification Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph - Product Code CHL
Product Stat Profile Critical Care Xpress CCX (R) Analyzer
Catalog Number: 37562
R= Refurbished
Code Information Serial Numbers: Inst. S/N Y01902211 Y01203021 Y01B02101 
Recalling Firm/
Nova Biomedical Corporation
200 Prospect St
Waltham MA 02453-3457
For Additional Information Contact Paul MacDonald
781-647-3700 Ext. 211
Manufacturer Reason
for Recall
Incorrectly assembled pumps may result in inconsistent compression of the tubing causing erratic results or calibration problems
FDA Determined
Cause 2
Action Nova Biomedical notified users by telephone on 3/31/04 and conducted follow-up by letter either by email or fax. On-site visit will be scheduled to replace the pump assembly.
Quantity in Commerce 3 units
Distribution CA, IL, LA, MA ,NJ, NY, OH, PA, TX International: Italy ,England, Japan,Turkey., U.A.E., Greece, Thailand, Switzerland, Finland, Saudi Arabia, Italy, Mexico, Trinidad, Ireland, France, Cyprus, Czech Republic, ,Germany
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.